US FDA conclude Lupin’s Nagpur Unit-1 facility inspection with zero observation EP News Bureau Nov 17, 2025 Lupin announced that the United States Food and Drug Administration (US FDA) has completed a product specific Pre-Approval…
Lupin’s Somerset facility clears U.S. FDA Pre-Approval Inspection for Edaravone Oral Suspension EP News Bureau Feb 3, 2025 Lupin announces completion of U.S. FDA Pre-Approval Inspection at its Somerset, New Jersey facility with zero 483 observations
Eugia Steriles receives EIR from US FDA EP News Bureau Sep 18, 2024 The inspection was conducted between March 28, 2024 to April 05, 2024
Granules Pharmaceuticals clears US FDA audit EP News Bureau Jul 22, 2021 The company had undergone the PAI audit by the US Food and Drug Administration (FDA) from 21st June, 2021 to 25th June, 2021